Detailansicht

Wissensnetz

Person

Thomas Berg (1963-)

Gastroenterologe

Name	Thomas Berg
Zeit	1963- (Lebensdaten)
Ort	Leverkusen (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Gastroenterologe (charakteristischer Beruf) Facharzt Internist
Variante	T. Berg
Beziehung	Charité - Universitätsmedizin Berlin (Seit 2002 Oberarzt und und seit 2006 stellvertretender Direktor der Medizinischen Klinik mit Schwerpunkt Hepatologie und Gastroenterologie) (1992-2009) Universitätsklinikum Leipzig (Leiter der Sektion Hepatologie der Klinik und Poliklinik für Gastroenterologie und Rheumatologie) (2009-) Hepatologie (Thema)
Weitere Angaben	Approbation 1995
Datensatztyp	Person
GND-Nummer	13378732X
Datensatz-ID	13378732X
Beteiligt an alle anzeigen Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis : results from a genome-wide case-control study Update Hepatologie 2024 : HepatologieUpdate 2024 A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B Klinikleitfaden Gastroenterologie und Hepatologie Update Hepatologie 2023 : HepatoUpdate 2023 A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort Klinikleitfaden Gastroenterologie und Hepatologie Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2 Facharztwissen Gastroenterologie Facharztwissen Gastroenterologie und Hepatologie Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-Registry Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: safety and effectiveness data from the German Hepatitis C‐Registry Primär biliäre Cholangitis (PBC) Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic Primär biliäre Cholangitis (PBC) rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis Handbuch Hepatologie 2019 : HepatoUpdate 2019 Primär biliäre Cholangitis (PBC) Primär sklerosierende Cholangitis (PSC) Acute-on-Chronic Liver Failure Handbuch Hepatologie 2018 : HepatoUpdate 2018 Handbuch Hepatologie 2017 : HepatoUpdate 2017 Handbuch Hepatologie 2016 : HepatoUpdate 2016 Hepatitis B vaccination in end-stage pulmonary disease patients evaluated for lung transplantation : a retrospective single-center evaluation Handbuch Hepatologie 2015 Handbuch Hepatologie 2014 PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C Simeprevir : Therapie der chronischen Hepatitis C mit Simeprevir, dem Proteasehemmer der nächsten Generation Hepatozelluläres Karzinom - ein interdisziplinäres Krankheitsbild Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development Handbuch Hepatologie 2013 A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C Handbuch Hepatologie 2012 : Hepato-Update 2012 High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany : a prospective screening analysis of 28,809 patients Gastro-Onko-Update-Manual - Diagnostik und Therapiestandards gastrointestinaler Tumore 2011 Empfehlungen des Bng zur Therapie der chronischen Hepatitis C 2007 Infektionskrankheiten : [verstehen, erkennen, behandeln] ; 93 Tabellen Zapalenie wa̜troby a zakażenie HIV : 34 tabele Chronische Hepatitis C : therapeutische Strategien, molekulare Resistenzmechanismen und Relevanz neuer Hepatitis-assoziierter Viren Chronische Hepatitis C : therapeutische Strategien, molekulare Resistenzmechanismen und Relevanz neuer Hepatitis-assoziierter Viren Langzeitbeobachtung chronisch Hepatits-C-Virus (HCV) infizierter Patienten nach orthotoper Lebertransplantation : Relevanz HCV-genomischer Merkmale für den Verlauf

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Thomas Berg (1963-)

Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease

Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis : results from a genome-wide case-control study

Update Hepatologie 2024 : HepatologieUpdate 2024

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Klinikleitfaden Gastroenterologie und Hepatologie

Update Hepatologie 2023 : HepatoUpdate 2023

A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression

Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort

Klinikleitfaden Gastroenterologie und Hepatologie

Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial

Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2

Facharztwissen Gastroenterologie

Facharztwissen Gastroenterologie und Hepatologie

Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-Registry

Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: safety and effectiveness data from the German Hepatitis C‐Registry

Primär biliäre Cholangitis (PBC)

Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

Primär biliäre Cholangitis (PBC)

rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

Handbuch Hepatologie 2019 : HepatoUpdate 2019

Primär biliäre Cholangitis (PBC)

Primär sklerosierende Cholangitis (PSC)

Acute-on-Chronic Liver Failure

Handbuch Hepatologie 2018 : HepatoUpdate 2018

Handbuch Hepatologie 2017 : HepatoUpdate 2017

Handbuch Hepatologie 2016 : HepatoUpdate 2016

Hepatitis B vaccination in end-stage pulmonary disease patients evaluated for lung transplantation : a retrospective single-center evaluation

Handbuch Hepatologie 2015

Handbuch Hepatologie 2014

PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C

Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C

Simeprevir : Therapie der chronischen Hepatitis C mit Simeprevir, dem Proteasehemmer der nächsten Generation

Hepatozelluläres Karzinom - ein interdisziplinäres Krankheitsbild

Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development

Handbuch Hepatologie 2013

A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C

Handbuch Hepatologie 2012 : Hepato-Update 2012

High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany : a prospective screening analysis of 28,809 patients

Gastro-Onko-Update-Manual - Diagnostik und Therapiestandards gastrointestinaler Tumore 2011

Empfehlungen des Bng zur Therapie der chronischen Hepatitis C 2007

Infektionskrankheiten : [verstehen, erkennen, behandeln] ; 93 Tabellen

Zapalenie wa̜troby a zakażenie HIV : 34 tabele

Chronische Hepatitis C : therapeutische Strategien, molekulare Resistenzmechanismen und Relevanz neuer Hepatitis-assoziierter Viren

Chronische Hepatitis C : therapeutische Strategien, molekulare Resistenzmechanismen und Relevanz neuer Hepatitis-assoziierter Viren

Langzeitbeobachtung chronisch Hepatits-C-Virus (HCV) infizierter Patienten nach orthotoper Lebertransplantation : Relevanz HCV-genomischer Merkmale für den Verlauf